» Articles » PMID: 38259336

Improving Naturalistic Neuroscience with Patient Engagement Strategies

Overview
Specialty Neurology
Date 2024 Jan 23
PMID 38259336
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The clinical implementation of chronic electrophysiology-driven adaptive deep brain stimulation (DBS) algorithms in movement disorders requires reliable representation of motor and non-motor symptoms in electrophysiological biomarkers, throughout normal life (naturalistic). To achieve this, there is the need for high-resolution and -quality chronic objective and subjective symptom monitoring in parallel to biomarker recordings. To realize these recordings, an active participation and engagement of the investigated patients is necessary. To date, there has been little research into patient engagement strategies for DBS patients or chronic electrophysiological recordings.

Concepts And Results: We here present our concept and the first results of a patient engagement strategy for a chronic DBS study. After discussing the current state of literature, we present objectives, methodology and consequences of the patient engagement regarding study design, data acquisition, and study infrastructure. Nine patients with Parkinson's disease and their caregivers participated in the meeting, and their input led to changes to our study design. Especially, the patient input helped us designing study-set-up meetings and support structures.

Conclusion: We believe that patient engagement increases compliance and study motivation through scientific empowerment of patients. While considering patient opinion on sensors or questionnaire questions may lead to more precise and reliable data acquisition, there was also a high demand for study support and engagement structures. Hence, we recommend the implementation of patient engagement in planning of chronic studies with complex designs, long recording durations or high demand for individual active study participation.

Citing Articles

Data Hazards as An Ethical Toolkit for Neuroscience.

Garcia S, Welsh C, Di Cara N, Sterratt D, Romano N, Stefan M Neuroethics. 2025; 18(1):15.

PMID: 39980970 PMC: 11835915. DOI: 10.1007/s12152-024-09580-3.

References
1.
Ferreira J, Santos A, Domingos J, Matthews H, Isaacs T, Duffen J . Clinical Parameters and Tools for Home-Based Assessment of Parkinson's Disease: Results from a Delphi study. J Parkinsons Dis. 2015; 5(2):281-90. DOI: 10.3233/JPD-140493. View

2.
van Rheede J, Feldmann L, Busch J, Fleming J, Mathiopoulou V, Denison T . Diurnal modulation of subthalamic beta oscillatory power in Parkinson's disease patients during deep brain stimulation. NPJ Parkinsons Dis. 2022; 8(1):88. PMC: 9270436. DOI: 10.1038/s41531-022-00350-7. View

3.
Sauerbier A, Jitkritsadakul O, Titova N, Klingelhoefer L, Tsuboi Y, Carr H . Non-Motor Symptoms Assessed by Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale in Parkinson's Disease in Selected Asian Populations. Neuroepidemiology. 2017; 49(1-2):1-17. DOI: 10.1159/000478702. View

4.
Habets J, Heijmans M, Herff C, Simons C, Leentjens A, Temel Y . Mobile Health Daily Life Monitoring for Parkinson Disease: Development and Validation of Ecological Momentary Assessments. JMIR Mhealth Uhealth. 2020; 8(5):e15628. PMC: 7248801. DOI: 10.2196/15628. View

5.
Morel T, Cleanthous S, Andrejack J, Barker R, Biagioni M, Blavat G . Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson's. J Patient Rep Outcomes. 2023; 7(1):40. PMC: 10119343. DOI: 10.1186/s41687-023-00577-9. View